Dr. Reddy's launches generic Boniva

HYDERABAD, India — Dr. Reddy's has launched a drug designed to prevent and treat osteoporosis.

The generic drug maker launched ibandronate sodium tablets in the 150-mg strength, following approval by the Food and Drug Administration for the drug maker's abbreviated new drug application. The drug is a generic version of Boniva.

The branded drug and generic versions had U.S. sales of approximately $486 million during the 12-month period ended in March, according to IMS Health.


Interested in this topic? Sign up for our weekly Collaborative Care e-newsletter.

Recommended stories

Login or Register to post a comment.